|
|
Article: Aphton Reports Efficacy of Gonadimmune for Treatment of Breast Cancer at Meeting of American Association of Cancer Research.
- Article from:
- Business Wire
- Article date:
- April 25, 1996
CopyrightCOPYRIGHT 1996 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WOODLAND, Calif.--(BUSINESS WIRE)--April 25, 1996--Aphton reported the results of a series of experiments demonstrating the efficacy of its product Gonadimmune(TM) in treatment of breast cancer.
The report was made at the American Association of Cancer Research (AACR) meeting held on April 24 in Washington, D.C., by scientists from the University of Nottingham, the City Hospital at Nottingham and Aphton Corp.
The experiments were carried out on a large number of immunodeficient animals which were implanted with a human-derived breast cancer. Results showed that anti-Gonadimmune(TM) antibodies caused a marked inhibition of tumor growth and a tripling of ...